Invention Grant
- Patent Title: Immune stimulating compound
-
Application No.: US16487813Application Date: 2018-02-22
-
Publication No.: US11059846B2Publication Date: 2021-07-13
- Inventor: Ola Winqvist , Emma Lindh , Robert Wallin , Matt Gregory , Steven Moss
- Applicant: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
- Applicant Address: SE Stockholm
- Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
- Current Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
- Current Assignee Address: SE Stockholm
- Agency: Dechert LLP
- Agent Carl A. Morales; Todd K. Macklin
- Priority: EP17157387 20170222
- International Application: PCT/EP2018/054340 WO 20180222
- International Announcement: WO2018/153957 WO 20180830
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; C07H17/08 ; A61P31/04
Abstract:
The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating intracellular bacterial, fungal, and protozoal infections.
Public/Granted literature
- US20200010499A1 NOVEL IMMUNE STIMULATING COMPOUND Public/Granted day:2020-01-09
Information query
IPC分类:
